Cove Neurosciences
Cove is a precision neuroscience company that addresses the unmet need for objective biomarkers of brain-related disorders to accelerate and de-risk clinical trials. As populations age, the prevalence of brain disorders increases, and clinical trial failure rates remain high. Biomarkers are needed since no two patients’ diseases are the same, yet we treat them the same. Backed by an experienced team of doctors, neuroscientists, and software engineers, Cove addresses this gap with CoveConnectTM, an end-to-end analytic platform for brain imaging data. CoveConnectTM is essential for pharmaceuticals, academia, and medical device companies studying the effects of medications and interventions on the human brain.
Contact: info@coveneuro.com
Dr. Nardin Samuel, MD, PhD (Co-Founder & CEO): nardin@coveneuro.com
Dr. Irene Harmsen, MD, PhD (Co-Founder & CTO): irene@coveneuro.com